Guide Management of Nonalcoholic Fatty Liver Disease
You’ll see more focus on managing nonalcoholic fatty liver disease (NAFLD)...partly due to new guidelines.
It’s being called a “sleeper epidemic.” About 1 in 4 patients have this steatosis...but most don’t have symptoms.
NAFLD often goes hand in hand with CV risk factors, such as insulin resistance or diabetes...obesity...and dyslipidemia.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote